Difference between revisions of "Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5 (Q9574)"
Jump to navigation
Jump to search
(Created claim: title (P93): Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy, #quickstatements; #temporary_batch_1590010982689) |
(Created claim: Page(s) (P105): 574-580, #quickstatements; #temporary_batch_1590074839150) |
||
| Property / Page(s) | |||
| + | 574-580 | ||
| Property / Page(s): 574-580 / rank | |||
| + | Normal rank | ||
Revision as of 15:37, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Chikuma S, et al. Cancer Sci. (2017) cited as Ref 311 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Chikuma S
0 references
Kanamori M
0 references
Mise-Omata S
0 references
2017
0 references
Cancer Sci.
0 references
108
0 references
Suppressors of cytokine signaling: potential immune checkpoint molecules for cancer immunotherapy (English)
0 references
574-580
0 references
